https://doi.org/10.4081/bse.97
Renewing potency assays: Moving forward from traditional methods
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Merck is global market leader in the fertility and growth hormone deficiency treatment. The quality control analytical panels for each new produced batch envisage the potency quantification that is estimated using a dedicated in vivo assay. Indeed, no in vitro methods for gonadotropin potency quantification are available in any pharmacopoeia. Merck Ivrea started a project to replace the in vivo assays with in vitro assays able to mimic the physiological mechanism of action of each gonadotropin and growth hormone.
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Similar Articles
- Maria Grazia Cascone, Luigi Lazzeri, Elisabetta Rosellini, Tissue engineered constructs for the replacement of laboratory animals: Biomimetics and microfluidics , Biomedical Science and Engineering: Vol. 1 No. 1 (2020)
- Beatrice Belgio, Sara Mantero, Federica Boschetti, Novel 3D in vitro retina model to investigate mechanisms involved in age-related macular degeneration , Biomedical Science and Engineering: Vol. 2 No. 1 (2021)
- Martina Brofiga, Marietta Pisano, Mariateresa Tedesco, Francesca Callegari, Paolo Massobrio, 3F(eature)s model: modularity, heterogeneity and three-dimensionality to design in vitro neuronal model , Biomedical Science and Engineering: Vol. 2 No. 1 (2021)
- Piera Mancini, Ermes Botte, Chiara Magliaro, Arti Ahluwalia, Toward scalable in vitro models: a novel experimental and computational pipeline for the identification of cellular metabolic parameters , Biomedical Science and Engineering: Vol. 2 No. 1 (2021)
- Giorgia Cerqueni, Annachiara Scalzone, Xiao Nong Wang, Caterina Licini, Kenny Dalgarno, Ana Marina Ferreira-Duarte, Piergiorgio Gentile, Monica Mattioli Belmonte, An osteochondral bio-engineered model to in vitro mimicking osteoarthritis , Biomedical Science and Engineering: Vol. 2 No. 1 (2021)
- Paola Petrini, Daniela Pacheco, Francesco Briatico Vangosa, Cosmin S. Butnarasu, Livia Visai, Orietta Monticelli, Laura Pastorino, Sonja Visentin, Hydrogel-based platforms to mimic in vivo drug diffusion: A multicenter research , Biomedical Science and Engineering: Vol. 1 No. 1 (2020)
- Eleonora Messuti, Martina Giambra, Serena Redaelli, Andrea Di Cristofori, Carlo Giussani, Angela Bentivegna, V-ATPase as a mediator of treatment resistance in Glioblastoma Multiforme: an in vitro study to investigate new therapeutic strategies , Biomedical Science and Engineering: Vol. 2 No. 1 (2021)
- G. Cattelan, G. Gentile, C. Volani, L. S. Frommelt, A. Lavdas, L. Foco, M. De Bortoli, C. Altomare, L. Barile, S. Zacchigna, P. P. Pramstaller, I. Pichler, A. Zanon, A. Rossini, A novel human iPSC-based co-culture model to study neurocardiac interaction in vitro , Biomedical Science and Engineering: Vol. 5 No. 1 (2024)
- Anna M. Bassi, Sara Tirendi, Sonia Scarfì, Mario Passalacqua, Vanessa Almonti, Stefania Vernazza, A millifluidic-based 3D-platform as a useful tool for the efficacy of glaucoma therapeutic strategies , Biomedical Science and Engineering: Vol. 3 No. 1 (2022)
- Licia Di Pietro, Alice Ravizza, Giovanni Vozzi, Andrés Diaz Lantada, Arti Ahluwalia, Carmelo De Maria, European regulatory framework for the clinical translation of bioprinted scaffolds and tissues , Biomedical Science and Engineering: Vol. 1 No. 1 (2020)
You may also start an advanced similarity search for this article.
